Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-24

Clinical Trial Update: Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intestinal permeability in eosinophilic esophagitis patients in response to treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Eosinophilic Esophagitis | Phase 1 | Status: COMPLETED